ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2022/2023 and the annual report for the fiscal year 2021/2022 would be published on November 24, 2022. Instead, the interim report and the annual report will be published on November 25, 2022, three weeks before the Annual General Meeting on December 16, 2022.For more information, please contact: Derek Simmross, CEO, ODI Pharma AB E-mail: info@odipharma.com ODI Pharma AB ODI Pharma, based on its European network, subsidiaries and affiliates, is a producer and